Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :25373633
Publication Date : //

Design of potential RNAi (miRNA and siRNA) molecules for Middle East respiratory syndrome coronavirus (MERS-CoV) gene silencing by computational method.


The Middle East respiratory syndrome coronavirus (MERS-CoV) is a virus that manifests itself in viral infection with fever, cough, shortness of breath, renal failure and severe acute pneumonia, which often result in a fatal outcome. MERS-CoV has been shown to spread between people who are in close contact. Transmission from infected patients to healthcare personnel has also been observed and is irredeemable with present technology. Genetic studies on MERS-CoV have shown that ORF 1ab encodes replicase polyproteins and play a foremost role in viral infection. Therefore, ORF 1ab replicase polyprotein may be used as suitable target for disease control. Viral activity can be controlled by RNA interference (RNAi) technology, a leading method for post transcriptional gene silencing in a sequence specific manner. However, there is a genetic inconsistency in different viral isolates; it is a great challenge to design potential RNAi (miRNA and siRNA) molecules which can silence the respective target genes rather than any other viral gene simultaneously. In current study four effective miRNA and five siRNA molecules for silencing of nine different strains of MERS-CoV were rationally designed and corroborated using computational methods, which might lead to knockdown the activity of virus. siRNA and miRNA molecules were predicted against ORF1ab gene of different strains of MERS-CoV as effective candidate using computational methods. Thus, this method may provide an insight for the chemical synthesis of antiviral RNA molecule for the treatment of MERS-CoV, at genomic level.

Authors : Nur Suza Mohammad , Hasan Md Anayet , Amin Mohammad Al , Hossain Mehjabeen , Sharmin Tahmina ,

Related products :

Catalog number Product name Quantity
JCI0I39 Middle East Respiratory Syndrome Coronavirus Real T ime P CR Kit 24T
65-102 anti_SARS antibody(clone 3A2) A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and 250 ug
65-101 anti_SARS antibody(clone 3A2) A novel type of coronavirus has been identified as the causative agent of SARS (Severe Acute Respiratory Syndrome). Spike glycoprotein is essential for the infection and 50 ug
MA-20018 Mouse Monoclonal Anti-Human severe acute respiratory syndrome (SARS-E2) Species Reactivity: human coronavirus 100 ul Product tipe: Antibodies
MA-20019 Mouse Monoclonal Anti-Human severe acute respiratory syndrome (SARS)-M Species Reactivity: human coronavirus 100 ul Product tipe: Antibodies
26-811 DNALI1 is the human homolog of the Chlamydomonas inner dynein arm gene, p28. The precise function of this gene is not known, however, it is a potential candidate for immotile cilia syndrome (ICS). Ult 0.05 mg
30-899 DNALI1 is the human homolog of the Chlamydomonas inner dynein arm gene, p28. The precise function of this gene is not known, however, it is a potential candidate for immotile cilia syndrome (ICS). Ult 0.05 mg
MD-05-0426 Rabbit Anti-SARS-Associated Coronavirus-Associated Coronavirus (SARS-CoV) Spike Protein (Middle) 100
MD-05-0430 Rabbit Anti-SARS-Associated Coronavirus-Associated Coronavirus (SARS-CoV) Spike Protein (Middle) 100
FR152 Fluhunter- Middle East -SARS-Real (Double check) FLUORGENIC REALTIME PCR - READY TO USE KIT 100 REACTIONS
FR151 Fluhunter- Middle East -SARS-Real (Single Check) FLUORGENIC REALTIME PCR - READY TO USE KIT 100 REACTIONS
YSRTMCA2194 Coronavirus, Feline Infectious Peritonitis Virus (FIPV) type 1 & 2, Canine Coronavirus (CCV), Swine Coronavirus Transmissable Gastroenteritis Virus (TGEV), Ferret Coronavirus, Clone FIPV3_70, Mab ant 0.25 mg.
ABP-CS-MBRI1 Gene-to-Silence RNAi service (5 RNAi clones per gene will be cloned and packaged, design is free); Titer 10^8 TU_ml; Volumn 2 ml 1
25-655 TNRC6A is a member of the trinucleotide repeat containing 6 protein family. The protein functions in post-transcriptional gene silencing through the RNA interference (RNAi) and microRNA pathways. The 0.05 mg
SL100568 Transfection Reagents and Kits, GenMute™ siRNA Transfection Reagent, formulated by PDCC technology, is a novel biodegradable non_liposomal siRNA & DNA delivery tool with exceptional silencing at 1.0 n 1 ml
SL100568 Transfection Reagents and Kits, GenMute™ siRNA Transfection Reagent, formulated by PDCC technology, is a novel biodegradable non_liposomal siRNA & DNA delivery tool with exceptional silencing at 1.0 n 0,5 ml
SL100568 Transfection Reagents and Kits, GenMute™ siRNA Transfection Reagent, formulated by PDCC technology, is a novel biodegradable non_liposomal siRNA & DNA delivery tool with exceptional silencing at 1.0 n 0,1 ml
SL100568 Transfection Reagents and Kits, GenMute™ siRNA Transfection Reagent, formulated by PDCC technology, is a novel biodegradable non_liposomal siRNA & DNA delivery tool with exceptional silencing at 1.0 n 0,5 ml
SL100568 Transfection Reagents and Kits, GenMute™ siRNA Transfection Reagent, formulated by PDCC technology, is a novel biodegradable non_liposomal siRNA & DNA delivery tool with exceptional silencing at 1.0 n 0,1 ml
SL100568 Transfection Reagents and Kits, GenMute™ siRNA Transfection Reagent, formulated by PDCC technology, is a novel biodegradable non_liposomal siRNA & DNA delivery tool with exceptional silencing at 1.0 n 1 ml
SL100575 Transfection Reagents and Kits, PepMute™ Transfection Buffer was formulated for PepMute™ siRNA Transfection Reagent for optimal transfection efficiency and maximum gene silencing. 8 ml
SL100575 Transfection Reagents and Kits, PepMute™ Transfection Buffer was formulated for PepMute™ siRNA Transfection Reagent for optimal transfection efficiency and maximum gene silencing. 4 ml
SL100574 Transfection Reagents and Kits, Powerfect™ Transfection Buffer was formulated for Powerfect™ siRNA Transfection Reagent for optimal transfection efficiency and maximum gene silencing. 8 ml
SL100574 Transfection Reagents and Kits, Powerfect™ Transfection Buffer was formulated for Powerfect™ siRNA Transfection Reagent for optimal transfection efficiency and maximum gene silencing. 4 ml
SL100573 Transfection Reagents and Kits, GenJet™ Transfection Buffer was formulated for GenJet™ siRNA Transfection Reagent for optimal transfection efficiency and maximum gene silencing. 8 ml


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur | Gentaur





GENTAUR Ltd.
Unicorn House, Station Cl
Hertfordshire, Potters Bar EN6 1TL
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017
RIB 30004 00187 00010092253 10
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
IBAN FR76 3000 4001 8700 0100 9225 310
france@gentaur.com | Gentaur | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: +49 0241 40 08 90 86, +49 0241 95 78 94 78, +49 0241 40 08 90 86
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur | Gentaur